Megace ES Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Megace ES
R
- RE-PB Hyos Elixir (atropine / hyoscyamine / phenobarbital / scopolamine)
- Recorlev (levoketoconazole)
- Relion Novolin 70 / 30 Innolet (insulin isophane / insulin regular)
- Relion Novolin N (insulin isophane)
- ReliOn NovoLog (insulin aspart)
- ReliOn/Humulin R (insulin regular)
- ReliOn / Novolin 70 / 30 (insulin isophane / insulin regular)
- ReliOn/Novolin R (insulin regular)
- repaglinide
- Repan (acetaminophen / butalbital / caffeine)
- repotrectinib
- Retevmo (selpercatinib)
- Rezulin (troglitazone)
- Rezvoglar (insulin glargine)
- rifabutin
- Rifadin (rifampin)
- Rifadin IV (rifampin)
- Rifamate (isoniazid / rifampin)
- rifampin
- rifapentine
- Rifater (isoniazid / pyrazinamide / rifampin)
- Rimactane (rifampin)
- Rinvoq (upadacitinib)
- Rinvoq LQ (upadacitinib)
- Riomet (metformin)
- Riomet ER (metformin)
- ritlecitinib
- Robimycin (erythromycin)
- rosiglitazone
- Rubraca (rucaparib)
- rucaparib
- rufinamide
- ruxolitinib
- ruxolitinib topical
- Rybelsus (semaglutide)
- Ryzodeg 70/30 (insulin aspart/insulin degludec)
More about Megace ES (megestrol)
- Megace ES consumer information
- Check interactions
- Compare alternatives
- Reviews (9)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: hormones/antineoplastics
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.